TheraCell was issued U.S. Patent No. 9,636,436, "Compositions of and Methods for Cancellous Bone Matrix," addressing its ECS™ enhanced cancellous demineralized bone technology.
K2M posted 1Q17 revenue of US $61.9MM, +9.9% vs. 1Q16. (U.S. $46.2MM, +9.5%; ex-U.S. $15.7MM, +11.1%) Following 1Q, the company received key product registrations from Japan’s Pharmaceuticals and Medical Devices Agency, and can now implement a new distribution strategy in that region.
Medtronic issued a Safety Notice related to use of non-Medtronic instruments with the NavLockâ„¢ Tracker, an accessory to its StealthStation Surgical Navigation system.Â
Life Spine announced that it has consistently doubled sales growth quarter over quarter since its 2Q16 introduction of the ProLift® Expandable Spacer.Â